Health Catalyst (HCAT)
(Delayed Data from NSDQ)
$8.83 USD
+0.09 (1.03%)
Updated Sep 19, 2024 04:00 PM ET
After-Market: $8.84 +0.01 (0.11%) 7:58 PM ET
3-Hold of 5 3
C Value B Growth B Momentum B VGM
Cash flow Statements
Fiscal Year End for Health Catalyst, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -118.15 | -137.40 | -153.21 | -115.02 | -60.10 |
Depreciation/Amortization & Depletion | 43.73 | 49.80 | 49.48 | 26.78 | 10.29 |
Net Change from Assets/Liabilities | -13.67 | -13.91 | -0.88 | 0.48 | -1.27 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 55.00 | 66.24 | 81.50 | 61.61 | 18.89 |
Net Cash From Operating Activities | -33.08 | -35.27 | -23.12 | -26.15 | -32.18 |
Property & Equipment | -13.16 | -15.13 | -17.07 | -9.20 | -2.34 |
Acquisition/ Disposition of Subsidiaries | -11.39 | -27.85 | -46.76 | -101.66 | 0.00 |
Investments | 45.97 | 6.21 | -74.47 | 29.54 | -205.33 |
Other Investing Activities | -1.12 | -2.26 | -1.37 | -1.25 | -1.94 |
Net Cash from Investing Activities | 20.29 | -39.02 | -139.68 | -82.57 | -209.60 |
Uses of Funds
12/31/2023 | 12/31/2022 | 12/31/2021 | 12/31/2020 | 12/31/2019 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 2.73 | -1.27 | 270.37 | 40.54 | 212.36 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 200.74 | -21.82 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | -1.34 | -6.29 | -58.67 | 40.85 |
Net Cash from Financing Activities | 2.73 | -2.61 | 264.08 | 182.61 | 231.38 |
Effect of Exchange Rate Changes | 0.02 | -0.01 | -0.01 | 0.03 | 0.01 |
Net Change In Cash & Equivalents | -10.04 | -76.92 | 101.27 | 73.92 | -10.40 |
Cash at Beginning of Period | 116.31 | 193.23 | 91.95 | 18.03 | 28.43 |
Cash at End of Period | 106.28 | 116.31 | 193.23 | 91.95 | 18.03 |
Diluted Net EPS | -2.09 | -2.63 | -3.23 | -2.91 | -12.86 |
Fiscal Year End for Health Catalyst, Inc falls in the month of December.
All data in Millions except Per Share data.
Cash Flow From Operations, Investments & Financial Activities
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Cash Flow From Operations, Investments & Financial Activities |
|||||
Net Income (Loss) | -34.10 | -20.59 | -118.15 | -87.84 | -65.80 |
Depreciation/Amortization & Depletion | 21.94 | 10.90 | 43.73 | 33.05 | 22.48 |
Net Change from Assets/Liabilities | 0.28 | 5.67 | -13.67 | -1.87 | -2.59 |
Net Cash from Discontinued Operations | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Operating Activities | 23.76 | 14.28 | 55.00 | 42.62 | 28.76 |
Net Cash From Operating Activities | 11.88 | 10.27 | -33.08 | -14.04 | -17.15 |
Property & Equipment | -6.78 | -2.74 | -13.16 | -10.29 | -7.21 |
Acquisition/ Disposition of Subsidiaries | -18.66 | 0.00 | -11.39 | 0.00 | 0.00 |
Investments | 108.00 | 86.80 | 45.97 | 1.65 | 23.41 |
Other Investing Activities | -0.37 | -0.08 | -1.12 | -0.99 | -0.97 |
Net Cash from Investing Activities | 82.20 | 83.98 | 20.29 | -9.62 | 15.23 |
Uses of Funds
6/30/2024 | 3/31/2024 | 12/31/2023 | 9/30/2023 | 6/30/2023 | |
---|---|---|---|---|---|
Issuance (Repurchase) of Capital Stock | 1.56 | 0.86 | 2.73 | 2.34 | 1.30 |
Issuance (Repayment) of Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Increase (Decrease) Short-Term Debt | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Payment of Dividends & Other Distributions | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Other Financing Activities | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
Net Cash from Financing Activities | 1.56 | 0.86 | 2.73 | 2.34 | 1.30 |
Effect of Exchange Rate Changes | -0.02 | -0.02 | 0.02 | -0.01 | 0.00 |
Net Change In Cash & Equivalents | 95.62 | 95.09 | -10.04 | -21.34 | -0.62 |
Cash at Beginning of Period | 106.28 | 106.28 | 116.31 | 116.31 | 116.31 |
Cash at End of Period | 201.90 | 201.37 | 106.28 | 94.97 | 115.69 |
Diluted Net EPS | -0.23 | -0.35 | -0.52 | -0.39 | -0.58 |